$GlaxoSmithKline (GSK.US)$ upcoming FDA decision premarket today stay tuned.

$GlaxoSmithKline (GSK.US)$ $182 per vaccine for influenza A n B.
$Uber Technologies (UBER.US)$ $Carnival (CCL.US)$ $AMC Entertainment (AMC.US)$ $Johnson & Johnson (JNJ.US)$ $Novo Nordisk A/S B Shares ADRhedged (NVOH.US)$ $Starbucks (SBUX.US)$ $McDonald's (MCD.US)$ $Netflix (NFLX.US)$ $Occidental Petroleum (OXY.US)$ $Alibaba (BABA.US)$ $CapitaLandInvest (9CI.SG)$ $Mapletree PanAsia Com Tr (N2IU.SG)$

$60 Degrees Pharmaceuticals (SXTP.US)$ so $GlaxoSmithKline (GSK.US)$ already uses and sells Arakoda for Malaria, this will help it with Babesiosis but would not be on the market until 2035, but more I read, the better this sounds about the potential.. and if this company needs money which i will check, they need the stock to run to do an offering so look for run to 3-4 before offering

Norway has just bought 11m doses of the $GlaxoSmithKline (GSK.US)$ H5N1 vaccine. $Novavax (NVAX.US)$ has already proven efficacy against H5N1, so they should mive fast to get orders in!

$CureVac (CVAC.US)$ $Novavax (NVAX.US)$ $Moderna (MRNA.US)$ $GlaxoSmithKline (GSK.US)$ $Nanoviricides (NNVC.US)$ $BioCryst Pharmaceuticals (BCRX.US)$ $Inovio Pharmaceuticals (INO.US)$ $Tonix Pharmaceuticals (TNXP.US)$ $Aethlon Medical (AEMD.US)$ $GeoVax Labs (GOVX.US)$
i forgot the others😂

$Pfizer (PFE.US)$ destroyed the shareholder confidence again. company isn't interested in shareholder value. latest threat of legal action against the former executives shows the company has no intention of curbing their careless cash spend. it's gone from creating value for shareholders to taking value from shareholders. bullies thinking they can do what they want with no repercussions. I hope their share price gets decimated over their poor decision to use forc...

$Pfizer (PFE.US)$  another positive, keep an eye $GlaxoSmithKline (GSK.US)$  $Apple (AAPL.US)$ $

$Pfizer (PFE.US)$ definitely an opportunity here to catch the rise, CEO will be meeting next week with new investor. discussions on directions will most likely be on the table and trimming the fat of recent acquisitions. speculation is making this stock rise until the news from the meeting is released. it's looking like there is more in the rumor mill and the price is reflecting it over the last couple sessions. keep an eye $Apple (AAPL.US)$ $Novo-Nordisk A/S (NVO.US)$  $GlaxoSmithKline (GSK.US)$